Arcadia Biosciences, based in Davis, California, develops and commercialises agriculture-based technologies that create value for growers and consumers while benefiting the environment and enhancing human health. The company was founded in 2002 to pursue agriculture-based business opportunities that improve the environment and human health. They use a number of technology tools - both GM and non-GM - to develop their product portfolio, including precise genetic screening, advanced breeding techniques and genetic engineering.
Arcadia has now received a Small Business Technology Transfer Program (STTR) grant from the National Institutes of Health in partnership with Washington State University (WSU) to research novel lines of wheat with reduced celiac disease-causing proteins. The grant was the first step in the company’s effort to identify and develop wheat varieties that can significantly expand the dietary options for people on gluten-free diets. Working with Dr. von Wettstein and his colleagues at WSU, Arcadia will use TILLING® technology to identify wheat plants in which harmful gluten proteins are minimized.
The research program is in its very early stages. See more here.
More research on the management of coeliac disease
Top of page